Polaris Group Sustainability Reports
Polaris Group is a multinational biopharmaceutical company focused on the research, development, manufacture, and sale of novel cancer therapies. Its core research centers on metabolic therapies and biological drugs such as Pegargiminase (ADI-PEG 20).
Sector: Manufacturing
Country: United States
Exchange: Taiwan Stock Exchange
FIGI: BBG00C19SMX7
6 reports from 2021 to 2024
